The objective of the project is to determine the effects of structural changes on the amine portion of phencyclidine (PCP) on its vitro and in vivo disposition and to use these findings to interpret the pharmacological actions of these compounds. Four structural analogs and 3 deuterium substituted derivatives of PCP will be used in the project. In the in vivo studies pharmacokinetic experiments measuring the plasma concentration of parent drug and two metabolites generated through oxidation of the alpha carbon will be conducted and the results analyzed by pharmacokinetic modeling procedures. The apparent rate constants for individual reactions for different congeners will be compared to assess effects of structural changes on metabolism in vivo. Pharmacological data will also be collected over time to determine the temporal relationship between drug, drug metabolite and pharmacologic effect. The in vitro experiments will determine quantitative and qualitative differences in cytochrome P450 mediated reactions resulting from structural changes and heavy isotope effects. The results of these enzymatic will address inconsistencies observed between in vitro and in vivo pharmacodynamics and the metabolic pathway for mechanism based inhibition of cytochrome P450 by PCP and its analogs. Finally, as part of a collaborative study, the pharmacokinetics of cocaine will also be determined to provide a basis for interpretation of tracer dose kinetics in larger animals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002411-13
Application #
2116569
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1979-08-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1994-03-31
Support Year
13
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Pharmacology
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kuczenski, R; Segal, D S; Cho, A K et al. (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-17
Hiratsuka, A; Chu, T Y; Distefano, E W et al. (1995) Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat. Drug Metab Dispos 23:201-6
Melega, W P; Williams, A E; Schmitz, D A et al. (1995) Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274:90-6
Pechnick, R N; Hiramatsu, M (1994) The effects of MK-801 on body temperature and behavior in the rat: cross-sensitization and cross-tolerance with phencyclidine. Eur J Pharmacol 252:35-42
Cho, A K; Hiramatsu, M; Kumagai, Y et al. (1993) Pharmacokinetic approaches to the study of drug action and toxicity. NIDA Res Monogr 136:213-25
Cho, A K; Hiramatsu, M; Schmitz, D A et al. (1993) A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine. J Pharmacol Exp Ther 264:1401-5
Lin, L Y; Kumagai, Y; Cho, A K (1992) Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes. Chem Res Toxicol 5:401-6
Burstyn, J N; Iskandar, M; Brady, J F et al. (1991) Comparative studies of N-hydroxylation and N-demethylation by microsomal cytochrome P-450. Chem Res Toxicol 4:70-6
Cho, A K; Hiramatsu, M; Schmitz, D A et al. (1991) Pharmacokinetic and pharmacodynamic properties of some phencyclidine analogs in rats. Pharmacol Biochem Behav 39:947-53
Bejanian, M; Pechnick, R N; George, R (1990) Effects of acute and chronic administration of (+)-SKF 10,047 on body temperature in the rat: cross-sensitization with phencyclidine. J Pharmacol Exp Ther 253:1253-8

Showing the most recent 10 out of 17 publications